Multiple Sclerosis, Rituximab, Hypogamma...

In the first part of this two-part series, Dr. Jeff Ratliff and Dr. Claire Henchcliffe discuss the important lessons learned from these results. Show reference: https://www.nature.com/articles/s41586-025-08845-y 

Dr. Jason Crowell and Dr. Brian E. Emmert discuss the concept behind the survey and the surprising findings from the survey results. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200221 

In part two of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the effect of temperature and precipitation on the incidence of West Nile Neuroinvasive Disease. Show reference: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00318-1/f ... Show More

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ... Show More

Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.m ... Show More

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and ... Show More

In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs. Key Concepts Addres ... Show More

Living with multiple sclerosis isn't just about managing the condition itself, but often involves navigating a myriad of additional health concerns known as comorbidities. Individuals with MS face a higher risk of experiencing new relapses when dealing with comorbidities like hig ... Show More

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for VTE treatment in patients with cancer and evaluating direct factor Xa inhibitors ... Show More

Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the full article in Neurology. 

mit Dr. med. Ron Philipps, Hausarzt und Rheumatologe (01:15) Polymyalgia rheumatica: Eine der häufigsten rheumatischen Erkrankungen | (02:04) Typische Symptome und Pathophysiologie | (03:42) Diagnostik | (05:39) Abgrenzung zur Riesenzellarteriitis | (10:01) Therapeutische Maßnahm ... Show More

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org. 

The Epstein-Barr virus (EBV) causes multiple sclerosis based on a new monumental study in young adults serving on active duty in the US military. The study found that the risk of developing MS increased 32-fold after infection with the Epstein-Barr virus. EBV causes infectious mo ... Show More